Year 2020 / Volume 27 / Number 4

PDF HTML

Avances en Dolor

Metamizole as an immunomodulator in neuropathic pain

Rev. Soc. Esp. Dolor. 2020; 27(4): 230-231 / DOI: 10.20986/resed.2020.3838/2020

Concepción Pérez






Complete Article

Nuevo comentario

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comentarios

No comments in this article

Bibliografía

1. Pérez C, Margarit C, Sánchez-Magro I, de Antonio A, Villoria J. Chronic Pain Features Relate to Quality of Life More than Physiopathology: A Cross-Sectional Evaluation in Pain Clinics. Pain Pract. 2017;17(7):866-78. DOI: 10.1111/papr.12533.
DOI: 10.1111/papr.12533
2. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9(8):807-19. DOI: 10.1016/S1474-4422(10)70143-5.
DOI: 10.1016/S1474-4422(10)70143-5
3. Pérez C, Ribera MV, Gálvez R, Micó JA, Barutell C, Failde I, et al. High prevalence of confirmed, but also of potential and believed, neuropathic pain in pain clinics. Eur J Pain. 2013;17(3):347-56. DOI: 10.1002/j.1532-2149.2012.00204.x
DOI: 10.1002/j.1532-2149.2012.00204.x
4. Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002. DOI: 10.1038/nrdp.2017.2.
DOI: 10.1038/nrdp.2017.2
5. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-73. DOI: 10.1016/S1474-4422(14)70251-0.
DOI: 10.1016/S1474-4422(14)70251-0
6. Binder A, Baron R. The Pharmacological Therapy of Chronic Neuropathic Pain. Dtsch Arztebl Int. 2016;113(37):616-25. DOI: 10.3238/arztebl.2016.0616.
DOI: 10.3238/arztebl.2016.0616
7. Pérez C, Navarro A, Saldaña MT, Wilson K, Rejas J. Modeling the predictive value of pain intensity on costs and resources utilization in patients with peripheral neuropathic pain. Clin J Pain. 2015;31(3):273-9. DOI: 10.1097/AJP.0000000000000110.
DOI: 10.1097/AJP.0000000000000110
8. Gonçalves Dos Santos G, Delay L, Yaksh TL, Corr M. Neuraxial Cytokines in Pain States. Front Immunol. 2020;10:3061. DOI: 10.3389/fimmu.2019.03061.
DOI: 10.3389/fimmu.2019.03061
9. Cook AD, Christensen AD, Tewari D, McMahon SB, Hamilton JA. Immune Cytokines and Their Receptors in Inflammatory Pain. Trends Immunol. 2018;39(3):240-55. DOI: 10.1016/j.it.2017.12.003.
DOI: 10.1016/j.it.2017.12.003
10. Skaper SD, Facci L, Zusso M, Giusti P. Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons. Neuroscientist. 2017;23(5):478-98. DOI: 10.1177/1073858416687249.
DOI: 10.1177/1073858416687249
11. Cairns BE, Arendt-Nielsen L, Sacerdote P. Perspectives in Pain Research 2014: Neuroinflammation and glial cell activation: The cause of transition from acute to chronic pain? Scand J Pain. 2015;6(1):3-6. DOI: 10.1016/j.sjpain.2014.10.002.
DOI: 10.1016/j.sjpain.2014.10.002
12. Zajaczkowska R, Kwiatkowski K, Pawlik K, Piotrowska A, Rojewska E, Makuch W, et al. Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain. Pharmacol Rep. 2020;10.1007/s43440-020-00137-8. DOI: 10.1007/s43440-020-00137-8.
DOI: 10.1007/s43440-020-00137-8
13. Nassini R, Fusi C, Materazzi S, Coppi E, Tuccinardi T, Marone IM, et al. The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives. Br J Pharmacol. 2015;172(13):3397-411. DOI: 10.1111/bph.13129.
DOI: 10.1111/bph.13129
14. Babej-Dölle R, Freytag S, Eckmeyer J, Zerle G, Schinzel S, Schmeider G, et al. Parenteral dipyrone versus diclofenac and placebo in patients with acute lumbago or sciatic pain: randomized observer-blind multicenter study. Int J Clin Pharmacol Ther. 1994;32(4):204-9.
Zhang W, Yu T, Cui X, Yu H, Li X. Analgesic effect of dexmedetomidine in rats after chronic constriction injury by mediating microRNA-101 expression and the E2F2/TLR4/NF-κB. Exp Physiol. 2020;10.1113/EP088596. DOI: 10.1113/EP088596.
DOI: 10.1113/EP088596

Artículos relacionados

Instrucciones para citar

Pérez C. Metamizole as an immunomodulator in neuropathic pain. Rev Soc Esp Dolor 2020; 27(4): 230-231 / DOI: 1020986/resed20203838/2020


Descargar a un gestores de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica

Este artículo ha sido visitado 27242 veces.
Este artículo ha sido descargado 9 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Aceptado: 30/07/2020

Prepublicado: 30/07/2020

Publicado: 04/08/2020


Compartir

Este artículo aun no tiene valoraciones.
Reader rating:
Rate this article:
Send by e-mail
© 2024 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

       Indexada en:
Política de Privacidad